Clinical Trial Update: Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation [NA]

View source ↗

Summary

A clinical trial investigating whether glial acetate metabolism can serve as a biomarker for hypoglycemic counterregulation in individuals with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Snippet

Sponsor: Pennington Biomedical Research Center | Conditions: Diabetes, Hypoglycemia | NA | Status: RECRUITING